CDC Responds to Multistate Outbreak of Fungal Meningitis and Other Infections
The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA), is investigating a multistate outbreak of fungal meningitis and other infections among patients who received contaminated steroid injections. This form of meningitis is not contagious. The investigation also includes fungal infections associated with the injection site, both spinal and peripheral joints, such as a knee, shoulder or ankle. See Current Situation Update
This website was last updated February 25, 2013 3:30 PM EST
At-A-Glance
- Status: Ongoing Investigation
- Infection: Fungal
- Facility Type: Outpatient Setting
- Case Count: 714*
- States: 20*
- Deaths: 48*
- Laboratory Results
Patient Guidance
Laboratory Guidance
News Media
- Digital Press Kit - CDC Responds to Multistate Meningitis OutbreakOctober 13, 2012
- CDC, FDA, Massachusetts Department of Public Health Joint Telebriefing Updating Investigation of Meningitis OutbreakOctober 11, 2012
- Press Release: Update on Nationwide Meningitis OutbreakOctober 5, 2012
- Press briefing transcript: CDC and FDA Joint Telebriefing on Investigation of Meningitis OutbreakOctober 4, 2012
Additional Agencies Involved
- U.S. Food and Drug Administration (FDA)
- Archive of Updates on Fungal Meningitis Outbreak
- Alert – New England Compounding Center Product Recall Information (Commonwealth of Massachusetts) [PDF - 24KB]
- FDA reports conditions observed at New England Compounding Center facility (FDA Press Release: Oct. 26, 2012)
- FDA announced the voluntary recall of all Ameridose products on October 31, 2012.
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC–INFO